Antimicrobial efficacy of two surface barrier discharges with air plasma against in vitro biofilms

Rutger Matthes1, Claudia Bender, Rabea Schlüter

  • 1Institute for Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany.

Plos One
|July 30, 2013
PubMed

Insights

Air plasma effectively combats microbial biofilms in chronic wounds, outperforming traditional antiseptics like chlorhexidine digluconate (CHX). This plasma therapy shows promise for wound treatment, though cell toxicity limits application duration.

Area of Science:

  • Plasma Medicine
  • Microbiology
  • Biomaterials

Background:

  • Chronic wounds often harbor microbial biofilms, reducing antiseptic efficacy.
  • Biofilms present a significant challenge in wound healing and infection control.

Purpose of the Study:

  • To compare the antibiofilm efficacy of two air plasma surface barrier discharges against microbial biofilms.
  • To evaluate the efficacy of air plasma against *Pseudomonas aeruginosa* and *Staphylococcus epidermidis* biofilms.
  • To assess the cytotoxicity and UV irradiance of the air plasma for potential therapeutic applications.

Main Methods:

  • Cultivation of *P. aeruginosa* and *S. epidermidis* biofilms on polycarbonate discs.
  • Treatment of biofilms with air plasma (30-600 s) or 0.1% chlorhexidine digluconate (CHX) (600 s).
  • Antimicrobial effect determination via colony forming units (CFUs) and scanning electron microscopy (SEM); cytotoxicity assessed using MTT assay.

Main Results:

  • Both air plasma sources demonstrated high antimicrobial efficacy against biofilms, surpassing CHX treatment.
  • Efficacy varied between bacterial strains and plasma sources.
  • Plasma treatment up to 150 s showed acceptable cytotoxicity for potential human tissue application, with negligible UV emission.

Conclusions:

  • Air plasma presents a viable therapeutic option for treating infected chronic wounds by effectively disrupting microbial biofilms.
  • Further research into optimizing plasma parameters is warranted to maximize efficacy and minimize cytotoxicity.
  • The low UV emission suggests plasma is safe for short-term application on human tissues.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...